Since PSA and PSA derivatives, such as PSA velocity, PSA density and free PSA fraction have all proven to be disappointing in distinguishing between BPH and prostate cancer44, RNASE4 represents a valuable alternative to these tests. Here, KLK3 is linked to benign prostatic hyperplasia.